Posterior Quadratus Lumborum Block Using 0.125% Versus 0.25% Bupivacaine for Analgesia in Children Undergoing LPEC

• Status: Recruiting
• Trial end date: 2022-06-30
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the present study is to evaluate and compare the analgesic efficiency of the difference concentration between 0.125% and 0.25% bupivacaine provided by ultrasound guided posterior quadratus lumborum block undergoing LPEC in children

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Queen Sirikit National Institute of Child Health
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Children scheduled for laparoscopic percutaneous extraperitoneal closure(LPEC) for pediatric inguinal hernia and hydrocele

• ASA I-II physical status patients

• Complete inform consent for intervention

Exclusion Criteria:

• Contraindication for regional anesthesia

• Sensitive to local anesthetic agent, opioid or acetaminophen

• Previous history of abdominal surgery

• History of neuromuscular disease

• G6PD deficiency